Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer

by fernando | Dec 18, 2025 | Media Coverage

Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic

by Cartography | Oct 3, 2025 | Media Coverage

Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team

by Cartography | Sep 3, 2025 | Media Coverage

Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors

by Cartography | Oct 29, 2024 | Media Coverage

Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs

by Cartography | May 28, 2024 | Media Coverage

Cartography Biosciences and Nested Therapeutics: Diamonds in the rough

by Cartography | Oct 2, 2023 | Media Coverage